Indonesian Political, Business & Finance News

Bio Farma Explores Research and Technology Partnerships at DTIIF 2026

| Source: Antara (Indonesian) Translated from Indonesian | Business
Bio Farma Explores Research and Technology Partnerships at DTIIF 2026
Image: Antara (Indonesian)

Jakarta (ANTARA) - PT Bio Farma (Persero) is exploring opportunities for research, innovation and technology-development partnerships with strategic domestic and international partners at the Danantara Technology Innovation and Investment Forum (DTIIF) 2026 in Jakarta, from 26 to 28 October 2026.

Bio Farma President Director Shadiq Akasya said the forum was an opportunity for the company to broaden cooperation with industry players, research institutions and investors to strengthen the development of Indonesia’s pharmaceutical products.

“Bringing a product to fruition requires research and development (R&D), innovation and technology. We hope this meeting will lead to something we can develop for Bio Farma,” Shadiq said in Jakarta on Monday.

At the forum, Bio Farma introduced several technological innovations, including a digital-based vaccine distribution monitoring system, the use of artificial intelligence (AI) in production and research, and virtual reality (VR) technology to improve staff skills.

One of the innovations on display was Medtrack, a real-time vaccine distribution monitoring system that tracks shipment temperatures and detects potential disruptions during distribution.

Bio Farma also uses AI to monitor the production process for polio vaccines and to research DNA- and mRNA-based vaccine candidates. The technology supports the analysis and selection of promising candidates for new product development.

VR technology is being applied to staff qualification through digital simulations, while the company continues to develop the digitisation of production and quality-control processes to improve operational efficiency.

Shadiq added that strengthening innovation was part of Bio Farma’s efforts to increase the competitiveness of Indonesia’s pharmaceutical industry, noting that the company’s polio vaccines are used in more than 150 countries.

In addition to meeting domestic vaccine needs, Bio Farma also supplies vaccines to international markets through UNICEF.

“I hope the forum will expand opportunities for cooperation with various strategic partners, including research companies and parties with the capacity to develop technology,” he concluded.

More from 27 October 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/bio-farma-explores-research-and-technology-partnerships-at-dtiif-2026-1793109217)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5815391/bio-farma-jajaki-kolaborasi-riset-dan-teknologi-melalui-dtiif-2026), translated from Indonesian
Print